Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Multiple Myeloma 36Neoplasms, Plasma Cell 12Prostatic Neoplasms 4Neoplasms 3Lymphoma, Mantle-Cell 3Immunoglobulin Light-chain Amyloidosis 3Central Nervous System Neoplasms 3Waldenstrom Macroglobulinemia 2Sarcoma 2Recurrence 2Rectal Neoplasms 2Neuroblastoma 2Lymphoma, Non-Hodgkin 2Lymphoma 2Lung Neoplasms 2Leukemia, Lymphocytic, Chronic, B-Cell 2Leukemia 2Glioma 2Glioblastoma 2Colorectal Neoplasms 2Colonic Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Amyloidosis 2Adenocarcinoma of Lung 2Renal Insufficiency, Chronic 1Renal Insufficiency 1Polyneuropathies 1Paraproteinemias 1Neurotoxicity Syndromes 1Motor Activity 1

Interventions

Thalidomide 1Melphalan 1Etoposide 1Doxorubicin 1Dexamethasone 1Cyclophosphamide 1Cisplatin 1Calcium Dobesilate 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Polyneuropathies × Thalidomide × Clear all
NCT01548573 2017-06-14

Tandem Auto Transplantation in Myeloma Patients With <12 Months of Prior Treatment

University of Iowa

Phase 2 Terminated
19 enrolled 7 charts
Plasma cell

Amyloidosis, Endocrine System Diseases, Multiple Myeloma, Paraproteinemias, Polyneuropathies

Data powered by HemOnc (CC BY 4.0) Colophon âš¡